FDA Inspection 1219020 — Merck & Co Inc
The FDA completed an inspection of Merck & Co Inc on Sep 1, 2023 in North Wales, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 1, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- North Wales, PA (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)